Annual Accounts Receivable
$26.96 M
-$20.12 M-42.74%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual accounts receivable is $26.96 million, with the most recent change of -$20.12 million (-42.74%) on December 31, 2023.
- During the last 3 years, KPTI annual accounts receivable has risen by +$14.08 million (+109.32%).
- KPTI annual accounts receivable is now -42.74% below its all-time high of $47.09 million, reached on December 31, 2022.
Performance
KPTI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$31.78 M
-$6.22 M-16.36%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly accounts receivable is $31.78 million, with the most recent change of -$6.22 million (-16.36%) on September 30, 2024.
- Over the past year, KPTI quarterly accounts receivable has dropped by -$6.22 million (-16.36%).
- KPTI quarterly accounts receivable is now -32.51% below its all-time high of $47.09 million, reached on December 31, 2022.
Performance
KPTI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
KPTI Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.7% | -16.4% |
| 3 y3 years | +109.3% | +69.5% |
| 5 y5 years | +100.0% | +300.8% |
KPTI Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.7% | +19.9% | -32.5% | +41.3% |
| 5 y | 5-year | -42.7% | +242.9% | -32.5% | +304.2% |
| alltime | all time | -42.7% | -100.0% | -32.5% | -100.0% |
Karyopharm Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $31.78 M(-16.4%) |
| Jun 2024 | - | $37.99 M(+22.2%) |
| Mar 2024 | - | $31.08 M(+15.3%) |
| Dec 2023 | $26.96 M(-42.7%) | $26.96 M(-28.9%) |
| Sep 2023 | - | $37.92 M(+17.5%) |
| Jun 2023 | - | $32.28 M(-8.3%) |
| Mar 2023 | - | $35.20 M(-25.2%) |
| Dec 2022 | $47.09 M(+109.3%) | $47.09 M(+71.6%) |
| Sep 2022 | - | $27.45 M(+16.9%) |
| Jun 2022 | - | $23.48 M(-6.1%) |
| Mar 2022 | - | $24.99 M(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $22.50 M(+74.7%) | $22.50 M(+20.0%) |
| Sep 2021 | - | $18.75 M(+4.8%) |
| Jun 2021 | - | $17.89 M(+0.2%) |
| Mar 2021 | - | $17.84 M(+38.5%) |
| Dec 2020 | $12.88 M(+63.8%) | $12.88 M(+16.4%) |
| Sep 2020 | - | $11.06 M(+15.5%) |
| Jun 2020 | - | $9.58 M(+3.2%) |
| Mar 2020 | - | $9.28 M(+18.0%) |
| Dec 2019 | $7.86 M(>+9900.0%) | $7.86 M(-0.8%) |
| Sep 2019 | - | $7.93 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Karyopharm Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual accounts receivable year-on-year change?
- What is Karyopharm Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly accounts receivable year-on-year change?
What is Karyopharm Therapeutics annual accounts receivable?
The current annual accounts receivable of KPTI is $26.96 M
What is the all time high annual accounts receivable for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual accounts receivable is $47.09 M
What is Karyopharm Therapeutics annual accounts receivable year-on-year change?
Over the past year, KPTI annual accounts receivable has changed by -$20.12 M (-42.74%)
What is Karyopharm Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of KPTI is $31.78 M
What is the all time high quarterly accounts receivable for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly accounts receivable is $47.09 M
What is Karyopharm Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, KPTI quarterly accounts receivable has changed by -$6.22 M (-16.36%)